Clinical trial
3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania…
NCT00159744 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00159744 |
|---|---|
| Title | 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008) |
| Official title | A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Safety and Efficacy of Sublingual Asenapine vs. Olanzapine and Placebo in In-Patients With an Acute Manic Episode Clinical Trial Protocol 7501004 (Secondary Title: ARES) |
| Lead sponsor | Organon and Co, Industry |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Asenapine, Olanzapine, Placebo |
| Enrollment | 488 |
| Start date | Nov 30, 2004 |
| Primary completion | Apr 29, 2006 |
| Completion | Apr 29, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: